Second-degree Burn Clinical Trial
Official title:
Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns
The evidence is insufficient to determine whether the types of dressings containing silver differ in time / proportion for complete wound healing and pain. We will analyze the cost-effectiveness of these dressings in outpatients, considering the service provided by the Brazilian National Public Health System.
Randomized, single-center, single-blinded, controlled clinical trial. Adult patients (age between 18 and 65 years), regardless of sex, with second degree burns treated in outpatient regimen will be randomized (1:1) into two groups: 1% silver sulfadiazine and nanocrystalline silver. Primary outcome: - Proportion of lesions completely epithelialized within 15 days. Secondary outcomes: - Time in days for complete epithelialization of the burned areas; - Number of dressing changes; - Level of pain associated with the application and removal of the dressings; - Direct medical and non-medical costs; - Need for surgery; - Incidence of infection; - Presence of local adverse reactions. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT04149808 -
Mepilex Ag vs. Xeroform in Pediatric Patients That Sustain Partial Thickness Burn Injury
|
N/A | |
| Recruiting |
NCT03048188 -
Manuka Honey in Second- and Grafted Third-degree Burns
|
N/A | |
| Completed |
NCT03530150 -
Pirfenidone and Its Role in Burn Wound Healing
|
Phase 2 |